
Indokem Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Indokem CMP Rs.505. Q1 FY27E revenue Rs.33-38 Cr. PAT estimate Rs.0-0 Cr. 12-month target Rs.404-470.
Updated: 8 Jul 2026 • 1:33 pm
Posted by:

Indokem Q1 Results FY27 is coming into focus as investors position ahead of the July-August 2026 results season, with Indokem shares trading at Rs.505 against a market capitalisation of Rs.1,399 Cr and a price-to-earnings multiple of 760.0. As a specialty chemicals name on the NSE and BSE, Indokem enters the Indokem Q1 Results FY27 print with the Street watching revenue momentum, margin trajectory and management commentary on FY27 guidance.
This Indokem Q1 Results FY27 preview is built on a trailing-growth framework applied to the company’s Q1 FY26 base of Rs.42 Cr revenue and Rs.1 Cr net profit, using the most recent year-on-year growth signal from Q4 FY26. This Q1 prediction is a Uniresearch trailing-growth projection, not a formal analyst estimate, and should be read alongside the company’s own guidance once released.
Get Free Investment Predictions and Indokem Research at Univest
About Indokem
Indokem (NSE: INDOKEM) operates in the specialty chemicals space and is tracked on Univest under its NSE and BSE listings. Ahead of the Indokem Q1 Results FY27 print, the company’s most recent reported quarter (Q4 FY26) shows revenue of Rs.46 Cr and net profit of Rs.0 Cr, forming the base against which the Indokem Q1 Results FY27 estimates in this article are built. This Indokem Q1 Results FY27 snapshot is intended as a starting point for research, not a substitute for the company’s own disclosures.
Indokem Q1 FY27 Estimates
| Metric | Q1 FY27E (Range) | Q1 FY26 Actual | YoY Growth |
|---|---|---|---|
| Revenue (Rs. Cr) | 33-38 | 42 | -15.9% |
| Net Profit / PAT (Rs. Cr) | 0-0 | 1 | -50.0% |
| Results Date | July-August 2026 (indicative) | ||
| 12-Month Target (Uniresearch Estimate) | Rs.404-470 | ||
Univest, a SEBI-Registered Investment Advisor, Tracks Indokem Ahead of Q1 FY27 Results
Key Catalysts to Watch
1. Realisation Stabilisation
Stabilising realisations after recent price volatility in key product segments is one of the primary variables that analysts are tracking ahead of Indokem’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Indokem share price target or faces renewed pressure.
2. Volume Growth
Volume growth from capacity utilisation improvement across manufacturing units is one of the primary variables that analysts are tracking ahead of Indokem’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Indokem share price target or faces renewed pressure.
3. Export Demand
Export demand recovery supporting topline in key specialty chemical categories is one of the primary variables that analysts are tracking ahead of Indokem’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Indokem share price target or faces renewed pressure.
Download the Univest iOS App or Univest Android App to track Indokem’s live price and Q1 FY27 result updates.
Key Risks to the Indokem Q1 Results FY27 Outlook
- Realisation volatility from global oversupply or demand softness.
- Input cost pressure from crude-linked or key raw material price swings.
- Regulatory or environmental compliance costs affecting margins.
Q4 FY26 Performance Context for the Indokem Q1 Results FY27 Print
Indokem closed Q4 FY26 with revenue of Rs.46 Cr and net profit of Rs.0 Cr, a year-on-year revenue change of -15.9% and PAT change of -91.1% versus Q4 FY25. This base underpins the Indokem Q1 Results FY27 projection used in this preview and should be read alongside the company’s own Indokem Q1 Results FY27 commentary once reported.
Technical Analysis Ahead of Indokem Q1 Results FY27
Indokem shares last traded at Rs.505. For the current 52-week high and low, support and resistance levels, investors should check the live chart on the Univest app or the NSE website, since these levels move intraday and are not reproduced here to avoid stale data.
Share Price Target Based on the Indokem Q1 Results FY27 Outlook
3-6 Month Target
Over a 3-6 month horizon, the Indokem Q1 Results FY27 trailing-growth framework points to a range of Rs.458-499 for Indokem, contingent on the Indokem Q1 Results FY27 print matching or beating the trailing growth trend.
12-Month Target
The 12-month target (Uniresearch estimate) tied to this Indokem Q1 Results FY27 view for Indokem works out to Rs.404-470, built on the same trailing revenue growth trend and current valuation multiple. Tracking with a cautious bias is how Univest research categorises the stock heading into Indokem Q1 Results FY27, not a formal Buy or Sell call.
FY27-28 Outlook
Looking out to FY27-28, a sustained continuation of the growth trajectory implied by this Indokem Q1 Results FY27 analysis would put Indokem in a Rs.369-460 range, though this is sensitive to sector-wide demand, cost trends and any change in the company’s competitive position.
What to Watch in the Indokem Q1 Results FY27 Print
- Revenue and PAT versus the Indokem Q1 Results FY27 estimate range in this preview.
- Management commentary on FY27 growth guidance and margin trajectory relevant to the Indokem Q1 Results FY27 narrative.
- Stabilising realisations after recent price volatility in key product segments
- Realisation volatility from global oversupply or demand softness
Conclusion on Indokem Q1 Results FY27
Indokem enters the Q1 FY27 results season trading at Rs.505, with the 12-month Uniresearch target range of Rs.404-470 reflecting a tracking with a cautious bias stance. Investors tracking the Indokem Q1 Results FY27 print should watch the catalysts and risks above and consult a SEBI-registered advisor before making investment decisions around the results.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Indokem Q1 Results FY27
When are Indokem Q1 FY27 results expected?
Ans. Indokem’s Q1 FY27 results are expected in the July-August 2026 window, in line with the broader NSE and BSE results season for the quarter ending June 2026.
What is the Indokem Q1 FY27 revenue estimate?
Ans. The Uniresearch trailing-growth estimate for Indokem’s Q1 FY27 revenue is Rs.33-38 Cr, based on the Q1 FY26 base of Rs.42 Cr.
What is the Indokem share price target?
Ans. The 12-month Uniresearch estimate for Indokem share price target is Rs.404-470, based on trailing growth and current valuation multiples.
Is Indokem a good buy before Q1 FY27 results?
Ans. Indokem is tracking with a cautious bias heading into Q1 FY27 results. Investors should weigh the catalysts and risks in this article and consult a SEBI-registered advisor before investing.
What should investors watch in Indokem’s Q1 FY27 results?
Ans. Key items include revenue and PAT versus estimates, management commentary on FY27 guidance, and stabilising realisations after recent price volatility in key product segments.
Where can I track Indokem share price live?
Ans. Indokem share price can be tracked live on the Univest app and website, along with research updates from SEBI-registered analysts.
Recent Articles

Divine Power Energy Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
8 July 2026

Fino Payments Bank Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
8 July 2026

Suraksha Diagnostic Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
8 July 2026

Natco Pharma Share Price Rises as Board Approves Rs 1,400 Crore South Africa Investment, Ups Adcock Ingram Stake
8 July 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Divine Power Energy Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Fino Payments Bank Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Suraksha Diagnostic Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Natco Pharma Share Price Rises as Board Approves Rs 1,400 Crore South Africa Investment, Ups Adcock Ingram Stake
Axis Solution Ltd. Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Popular this week
Divine Power Energy Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Fino Payments Bank Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Suraksha Diagnostic Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Natco Pharma Share Price Rises as Board Approves Rs 1,400 Crore South Africa Investment, Ups Adcock Ingram Stake
Axis Solution Ltd. Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





